Holding(s) in Company

RNS Number : 2886S
Spire Healthcare Group PLC
06 July 2015
 



 TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES

 

1.   Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Spire Healthcare Group plc

 

2. Reason for the notification (please state Yes/No):

 

An acquisition or disposal of voting rights:                               

 

An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached:

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments:                                            YES

 

An event changing the breakdown of voting rights: (    )

 

Other (please specify): 

 

3. Full name of person(s) subject to the notification obligation:

 

Goldman sachs asset investment management international

 

4. Full name of shareholder(s) (if different from 3.):

 

 

 

5. Date of the transaction (and date on which the threshold is crossed or reached if different):                                               26 June 2015

 

6. Date on which issuer notified:                       30 June 2015

    

 

7. Threshold(s) that is/are crossed or reached:         Above 5%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of  voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

ORDINARY


ISIN: GB00BNLPYF73

Below 5%

Below 5%

7,672,686

7,672,686


1.91%


B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financial instrument


Expiration Date




Exercise/Conversion Period/ Date



Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights




C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financial instrument

Exercise price

Expiration date

Exercise/conversion period

Number of voting rights instruments refers to

% of voting rights

 

Please refer to annexure A

 

13,951,828

Nominal

 

Delta

3.48%

 

 

Total (A+B+C)

Number of voting rights

21,624,514

% of voting rights

5.39%



9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

 

N/A

 

Proxy Voting:

 

10. Name of the proxy holder:                                                                N/A

     

                       

11. Number of voting rights proxy holder will cease to hold:        N/A

     

 

12. Date on which proxy holder will cease to hold voting rights: N/A

 

 

13. Additional information:                     

 

14. Contact name:

Anthony Dand, Interim Deputy Secretary, Spire Healthcare Group plc

 

15. Contact telephone number:

+ 44 (0)20 7427 9092

 

 

Annexure A







Attached to notification of voting rights given in fulfilment of the obligations imposed by the FCA in accordance with DTR5 (including section 5.8.1). by The Goldman Sachs Asset Management International dated 26 June 2015 for itself and its subsidiaries in relation to Spire Healthcare Group plc








Type of Financial Instrument

Expiration Date

Exercise / Conversion Period/Date

Number of voting rights that may be acquired if the instrument is exercised / converted

% of voting rights that may be obtained if the instrument is exercised/converted


Swap

17-Jan-2020

17-Jan-2020

13,143,630

3.28%


Swap

3-Oct-2019

3-Oct-2019

808,198

0.20%


Total Number of voting rights and percentage of voting rights

13,951,828

3.48%








 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUNUORVNABRAR
UK 100

Latest directors dealings